These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

786 related items for PubMed ID: 30343637

  • 1. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G, Vulquin N.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818806498. PubMed ID: 30343637
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
    Guan Y, Xiong J, Pan M, Shi W, Li J, Zhu H, Gong X, Li C, Mei G, Liu X, Pan L, Dai J, Wang Y, Wang E, Wang X.
    BMC Cancer; 2021 Feb 05; 21(1):123. PubMed ID: 33546642
    [Abstract] [Full Text] [Related]

  • 3. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ.
    Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):293-8. PubMed ID: 10030252
    [Abstract] [Full Text] [Related]

  • 4. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
    McKenzie JT, Guarnaschelli JN, Vagal AS, Warnick RE, Breneman JC.
    J Neurooncol; 2013 Jul 15; 113(3):403-9. PubMed ID: 23589034
    [Abstract] [Full Text] [Related]

  • 5. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J, Chaltiel L, Lubrano V, Sol JC, Lanaspeze C, Vieillevigne L, Latorzeff I, Cohen-Jonathan Moyal E.
    J Neurooncol; 2018 Jan 15; 136(2):413-419. PubMed ID: 29273890
    [Abstract] [Full Text] [Related]

  • 6. Salvage stereotactic radiosurgery for recurrent gliomas with prior radiation therapy.
    Sutera PA, Bernard ME, Gill BS, Quan K, Engh JA, Burton SA, Heron DE.
    Future Oncol; 2017 Dec 15; 13(29):2681-2690. PubMed ID: 29198146
    [Abstract] [Full Text] [Related]

  • 7. Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy.
    Kim B, Soisson E, Duma C, Chen P, Hafer R, Cox C, Cubellis J, Minion A, Plunkett M, Mackintosh R.
    Clin Neurol Neurosurg; 2011 Jul 15; 113(6):509-12. PubMed ID: 21392883
    [Abstract] [Full Text] [Related]

  • 8. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T, Maitre M, Maitre P, Goda JS, Krishnatry R, Chatterjee A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Jalali R.
    Clin Transl Oncol; 2021 Jul 15; 23(7):1358-1367. PubMed ID: 33528810
    [Abstract] [Full Text] [Related]

  • 9. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L, Falkov A, Chelimo C, Fogh SE.
    Clin Oncol (R Coll Radiol); 2018 Sep 15; 30(9):563-570. PubMed ID: 29891395
    [Abstract] [Full Text] [Related]

  • 10. Hypofractionated reirradiation for recurrent malignant glioma.
    Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, Bamberg M, Belka C.
    Strahlenther Onkol; 2009 Feb 15; 185(2):113-9. PubMed ID: 19240998
    [Abstract] [Full Text] [Related]

  • 11. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J, Neil E, Terziev R, Gutin P, Barani I, Kaley T, Lassman AB, Chan TA, Yamada J, DeAngelis L, Ballangrud A, Young R, Panageas KS, Beal K, Omuro A.
    Int J Radiat Oncol Biol Phys; 2017 Nov 15; 99(4):797-804. PubMed ID: 28870792
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
    Wuthrick EJ, Curran WJ, Camphausen K, Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik M, Haacke EM, Hillman GG, Dicker AP.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):369-75. PubMed ID: 25104067
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
    Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KB, Friedman HS, Willett CG, Kirkpatrick JP.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):2018-24. PubMed ID: 21489708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
    Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH.
    Int J Radiat Oncol Biol Phys; 2013 Mar 01; 85(3):636-42. PubMed ID: 22765876
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D, Kölbl O, Ruprecht K, Vince GH, Bratengeier K, Flentje M.
    BMC Cancer; 2005 May 30; 5():55. PubMed ID: 15924621
    [Abstract] [Full Text] [Related]

  • 20. [Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression].
    Chuguev AS, Kobyletskaya TM, Gerasimov VA, Belikova AA, Kaprin AD, Datsenko PV.
    Zh Vopr Neirokhir Im N N Burdenko; 2024 May 30; 88(5):23-29. PubMed ID: 39422680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.